Skip to main content
Neuromeka Co., Ltd. logo

Neuromeka Co., Ltd. — Investor Relations & Filings

Ticker · 348340 ISIN · KR7348340001 KO Manufacturing
Filings indexed 188 across all filing types
Latest filing 2026-03-19 Audit Report / Informat…
Country KR South Korea
Listing KO 348340

About Neuromeka Co., Ltd.

https://en.neuromeka.com/

Neuromeka is a robotics company specializing in the development and manufacturing of collaborative robots (cobots). The company's core business is centered on a comprehensive robot platform ecosystem designed to simplify the implementation and operation of automation solutions. Its product portfolio includes a range of cobots, delta robots, and mobile robots. Neuromeka also provides system integration services and is developing a Robot as a Service (RaaS) platform. The company's solutions are applied across various sectors, including manufacturing, food and beverage services, and media applications.

Recent filings

Filing Released Lang Actions
사업보고서 (2025.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Neuromeka, including the independent auditor's opinion, consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. It covers the fiscal year ending December 31, 2025. While it contains financial statements, it is explicitly titled as an audit report and serves as the formal audit documentation, which fits the 'AR' category. FY 2025
2026-03-19 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted to the Korea Exchange (KRX). It contains the auditor's opinion, financial statements (consolidated and separate), and key financial metrics for the fiscal year. While it contains audit-related information, in the context of Korean regulatory filings (DART/KIND), this specific disclosure format is the standard way companies announce the receipt and submission of their annual audit report, which is a mandatory regulatory requirement. Therefore, it is classified as an Audit Report (AR). FY 2025
2026-03-19 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (DART system) used by companies to solicit proxies from shareholders for an upcoming Annual General Meeting (AGM). It contains the agenda, information about the solicitors, and financial statements (as required by the proxy solicitation rules). This falls under the category of Proxy Solicitation & Information Statement.
2026-03-12 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Neuromeka, which includes the agenda, meeting details, and management information (such as board activities and financial statements). This type of document is specifically designed to provide shareholders with the necessary information to vote on matters at the AGM, making it a Proxy Solicitation & Information Statement.
2026-03-12 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date that coincides with other companies' meetings, citing internal audit and closing procedures. Since this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves (AGM-R) or a proxy statement (PSI), it falls under the general regulatory filing category.
2026-03-12 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Neuromeka. It outlines the date, location, agenda items (such as financial statement approval, director appointments, and business purpose changes), and details regarding the meeting. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2026-03-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.